Browse Category

EPA:ABVX.PA News 10 December 2025 - 12 January 2026

Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Paris, Jan 12, 2026, 11:17 CET — Regular session Shares in ABIVAX Société Anonyme surged Monday following a French media report that stirred new takeover speculation involving the biotech and U.S. pharmaceutical giant Eli Lilly. (Reuters) The stock climbed roughly 22% to 120.60 euros, hitting a peak of 130 euros earlier, based on Euronext-tracked quotes. It closed at 99 euros on Friday. (MarketScreener Canada) Why it matters now: Abivax is among the busiest biotech stocks in Paris at these levels, with even whispers of a deal sending its shares sharply higher. A one-day surge above 20% puts short-term funds on
Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

PARIS, Jan 8, 2026, 20:02 (CET) — Market closed Shares in French biotech Abivax SA (ABVX.PA) closed down 9.49% at 99.20 euros on Thursday, after swinging between 112.40 euros at the open and a low of 94.20 euros. The stock slipped back under the 100-euro mark, with volume at about 246,000 shares, after a 6% rise the day before. MarketScreener The selling pressure comes as investors look ahead to key readouts for obefazimod, Abivax’s lead drug candidate for ulcerative colitis, a chronic inflammatory bowel disease. Abivax has told investors topline results from its Phase 3 maintenance study are expected in
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme (Euronext Paris: ABVX, Nasdaq: ABVX) is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in which the French biotech has transformed from a relatively obscure name into a multibillion‑euro inflammatory bowel disease (IBD) contender.Reuters+1 Below is a detailed rundown of today’s news, the fundamental drivers, and the latest forecasts and analyses being published about Abivax. 1. Abivax stock today: how big is the move? On December 10, 2025, Abivax shares on Euronext Paris traded around

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop